Information Technology·Application Software·$6.6B
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | -$0.46 | N/A | +45.69% |
| Revenue | N/A | N/A | N/A |
management commentary, guidance changes, and full analysis available with Pro.
| EPS | -$0.46 | N/A | +45.69% |
| Revenue | N/A | N/A | N/A |
Tone: Cautiously Optimistic
Management expressed satisfaction with the EPS results, highlighting efforts to enhance operational efficiency. They emphasized a commitment to navigating market challenges.
We are pleased with our EPS performance this quarter.
Our focus remains on improving operational efficiency.
Core Scientific's better-than-expected EPS indicates improved financial performance, which likely contributed to the stock's 7.09% increase. Investors may view this as a positive sign of the company's ability to manage costs effectively. However, the lack of revenue data and guidance leaves some uncertainty about future growth prospects.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
INTUITIVE SURGICAL I
Oct 21, 2025